← Back to headlines
Edgewise Therapeutics Reports GAAP EPS of -$0.53
Edgewise Therapeutics announced its GAAP Earnings Per Share (EPS) for the latest period, reporting a loss of $0.53 per share.
6 Aug, 12:15 — 6 Aug, 12:15
Sources
Showing 1 of 1 sources
